Literature DB >> 22811643

The coordinated clinical studies network: a multidisciplinary alliance to facilitate research and improve care.

Sarah M Greene, Eric B Larson, Denise M Boudreau, Karin E Johnson, James Ralston, Robert Reid, Paul Fishman.   

Abstract

The NIH Roadmap is a major effort to reshape the US health research enterprise to accelerate medical discovery and to do so in such a way that actually hastens population health improvement through research. The Roadmap's ultimate goal resonates with the HMO Research Network, a consortium of integrated health care systems that uses its collective scientific capabilities to integrate research, practice, and policy for the improvement of health and health care among diverse populations. (See page 6 for abstracts from the HMO Research Network annual conference.) As such, the HMO Research Network was ideally suited to propose a new consortium project as a part of the NIH Roadmap, the Coordinated Clinical Studies Network (CCSN). The CCSN was funded in 2004 to create a path-breaking research facility that leverages several distinctive features of the HMO Research Network: the multidisciplinary scientific capabilities of its researchers; the ability to rapidly move clinical research findings into care delivery; its large, diverse patient populations; and a commitment to placing its findings in the public domain. Among the goals of the CCSN are to augment the capacity and infrastructure for conducting research, and to use considerable investments in health informatics to improve the scope and efficiency of research data collection. The NIH Roadmap is a revolutionary step toward a new paradigm for research and responds to both a compelling social need and rapid technological advances in biomedicine. The CCSN's participation in the Roadmap Initiative is a unique opportunity for researchers, clinicians, and our patients.

Entities:  

Year:  2005        PMID: 22811643      PMCID: PMC3396093          DOI: 10.7812/TPP/05-100

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  11 in total

1.  Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics.

Authors:  R Platt; R Davis; J Finkelstein; A S Go; J H Gurwitz; D Roblin; S Soumerai; D Ross-Degnan; S Andrade; M J Goodman; B Martinson; M A Raebel; D Smith; M Ulcickas-Yood; K A Chan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Aug-Sep       Impact factor: 2.890

2.  A central institutional review board for multi-institutional trials.

Authors:  Michaele C Christian; Jacquelyn L Goldberg; Jack Killen; Jeffrey S Abrams; Mary S McCabe; Joan K Mauer; Robert E Wittes
Journal:  N Engl J Med       Date:  2002-05-02       Impact factor: 91.245

3.  Medicine. The NIH Roadmap.

Authors:  Elias Zerhouni
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

4.  The role of research in integrated healthcare systems: the HMO Research Network.

Authors:  Thomas M Vogt; Jennifer Elston-Lafata; Dennis Tolsma; Sarah M Greene
Journal:  Am J Manag Care       Date:  2004-09       Impact factor: 2.229

5.  A clinical research strategy to support shared decision making.

Authors:  Sean R Tunis
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Feb       Impact factor: 6.301

6.  Organizational barriers to physician participation in cancer clinical trials.

Authors:  Carol P Somkin; Andrea Altschuler; Lynn Ackerson; Ann M Geiger; Sarah M Greene; Judy Mouchawar; Joan Holup; Louis Fehrenbacher; Andrew Nelson; Andrew Glass; Jonathan Polikoff; Sigrid Tishler; Carolyn Schmidt; Terry Field; Edward Wagner
Journal:  Am J Manag Care       Date:  2005-07       Impact factor: 2.229

7.  Impact of IRB requirements on a multicenter survey of prophylactic mastectomy outcomes.

Authors:  Sarah M Greene; Ann M Geiger; Emily L Harris; Andrea Altschuler; Larissa Nekhlyudov; Mary B Barton; Sharon J Rolnick; Joann G Elmore; Suzanne Fletcher
Journal:  Ann Epidemiol       Date:  2005-07-06       Impact factor: 3.797

8.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

Review 9.  Building a research consortium of large health systems: the Cancer Research Network.

Authors:  Edward H Wagner; Sarah M Greene; Gene Hart; Terry S Field; Suzanne Fletcher; Ann M Geiger; Lisa J Herrinton; Mark C Hornbrook; Christine C Johnson; Judy Mouchawar; Sharon J Rolnick; Victor J Stevens; Stephen H Taplin; Dennis Tolsma; Thomas M Vogt
Journal:  J Natl Cancer Inst Monogr       Date:  2005

10.  Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?

Authors:  Stephen H Taplin; Laura Ichikawa; Marianne Ulcickas Yood; M Michele Manos; Ann M Geiger; Sheila Weinmann; Joyce Gilbert; Judy Mouchawar; Wendy A Leyden; Robin Altaras; Robert K Beverly; Deborah Casso; Emily Oakes Westbrook; Kimberly Bischoff; Jane G Zapka; William E Barlow
Journal:  J Natl Cancer Inst       Date:  2004-10-20       Impact factor: 13.506

View more
  1 in total

1.  Sustaining Research Networks: the Twenty-Year Experience of the HMO Research Network.

Authors:  John F Steiner; Andrea R Paolino; Ella E Thompson; Eric B Larson
Journal:  EGEMS (Wash DC)       Date:  2014-06-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.